A public health research consortium is designing a pragmatic, randomized controlled trial to evaluate a novel mobile health intervention for patients with inadequately controlled type 2 diabetes mellitus. The preliminary sample size analysis indicates that with the maximum feasible recruitment of patients, the trial will have power to detect a clinically meaningful difference in the primary outcome (absolute change in hemoglobin A1c at 6 months). Due to strict grant limitations, the investigators cannot increase the sample size or extend the enrollment period. The principal investigator asks the team to propose methodological modifications that will increase the statistical power of the study to at least without requiring additional participants.
Which of the following study design or analysis modifications are most likely to increase the statistical power of this trial? (Select all that apply.)
- AExpanding the inclusion criteria to enroll patients with a wider range of baseline hemoglobin A1c values and diverse comorbidities
- BDichotomizing the primary outcome into clinical success (hemoglobin A1c < 7.0%) versus failure rather than analyzing it as a continuous variable
- Changing the statistical plan to use a one-tailed hypothesis test instead of a two-tailed test, given strong preliminary data that the intervention will not worsen glycemic controlAnswer
- Adjusting for baseline hemoglobin A1c levels and other strong prognostic covariates in the final analysis using an analysis of covariance (ANCOVA) modelAnswer
- EDecreasing the pre-specified significance level () from 0.05 to 0.01 to establish a more rigorous threshold for statistical significance